Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Completed · Phase 3

Conditions studied: Ocular Hypertension

In brief

The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Key facts

Study ID

NCT00332384

Run by

Allergan

People needed

573

Starts

2000-01-01

Expected to finish

2001-11-01

Last updated by the study team

2011-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
• Patient requires IOP-lowering drug in both eyes

You may not qualify if…

• Uncontrolled medical conditions
• contraindication to beta-adrenoceptor antagonist or brimonidine therapy

Where it is running

• Study site — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.